Lisata Therapeutics Inc.

NASDAQ: LSTA · Real-Time Price · USD
2.52
-0.04 (-1.56%)
At close: Aug 15, 2025, 3:59 PM
2.53
0.40%
After-hours: Aug 15, 2025, 04:00 PM EDT

Lisata Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-18.92M -19.31M -19.98M -20.74M -21.07M -20.05M -20.84M -21.46M -53.59M -56.19M -54.23M -55.03M -24.57M -23.63M -27.47M -26.1M -24.5M -12.22M
Depreciation & Amortization
170K 171K 174K 180K 185K 187K 189K 189K 150K 110K 69K 30K 36K 46K 55K 64K 66K 64K
Stock-Based Compensation
1.97M 1.73M 1.65M 1.25M 1.23M 1.82M 2.04M 2.03M 2.77M 2.55M 2.64M 2.53M 2.27M 2.17M 2M 1.81M 1.27M 1.29M
Other Working Capital
1.42M 2.27M 995K 1.33M 225K 104K -550K 269K 242K 87K 660K 184K -339K -667K -603K -1.04M 78K -2.31M
Other Non-Cash Items
-1.31M -1.19M -1.2M -1.09M -1.31M -2M -2.11M -1.14M 29.53M 30.5M 31.18M 31.88M 2.28M 2.71M 2.51M 2.06M 1.4M 611K
Deferred Income Tax
n/a n/a n/a 826K 826K 1.15M 1.15M 325K 325K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
1.69M 864K n/a 669K 172K 32K -462K -2.38M -2.03M -701K -831K 1.28M -357K -1.2M 647K -1.04M 78K -2.31M
Operating Cash Flow
-16.4M -17.73M -19.36M -18.9M -19.96M -18.86M -20.03M -22.43M -22.85M -23.72M -21.17M -19.31M -20.35M -19.91M -22.25M -23.21M -21.69M -12.56M
Capital Expenditures
-56K -28K n/a n/a n/a n/a n/a -26K -50K -285K -285K -319K -295K -120K -120K -66K -66K -18K
Cash Acquisitions
100K 100K n/a -130K -100K -100K n/a 3.32M n/a n/a n/a -3.32M n/a n/a n/a n/a n/a n/a
Purchase of Investments
-36.28M -41.95M -55.69M -65.08M -66.26M -87.18M -98.48M -98.56M -120.23M -93.26M -89.69M -110.93M -104.27M -130.41M -179.78M -150.31M -132.36M -110.71M
Sales Maturities Of Investments
41.43M 58.2M 69.05M 71.34M 90.94M 99.53M 108.58M 121.51M 126.53M 136.16M 122.2M 152.77M 155.45M 134.57M 124.94M 79.93M 46M 27.26M
Other Investing Acitivies
-174K -102K -130K n/a 100K -725 3.56K -3.32M 6.68M -3.32M -3.33M 53.91K -9.94M 47.71K -11.29K -70.38K -86.36K -83.45K
Investing Cash Flow
5.02M 16.23M 13.23M 6.13M 24.69M 12.25M 10.1M 22.92M 12.93M 39.29M 28.91M 38.26M 40.94M 4.1M -54.9M -70.44M -86.43M -83.47M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
142.00 142.00 -141.86K -141.86K -148K -148K -6.08K -6.08K -184 -184 -267 -267 -232 -232 -64 -64 n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-385K -375K -132K n/a n/a 452K 367K 367K 268K -184K -267K -267K -232K -232K -224K -224K -160K -160K
Financial Cash Flow
-55K -87K -206K -86K -92K 328K 385K 375K 282K -141K -224K -217K -182K -189K 85.28M 85.27M 94.36M 104.03M
Net Cash Flow
-11.46M -1.59M -6.38M -12.92M 4.6M -6.35M -9.56M 950K -9.66M 15.41M 7.51M 18.71M 20.41M -16M 8.13M -8.38M -13.75M 8M
Free Cash Flow
-16.4M -17.73M -19.36M -18.9M -19.96M -18.86M -20.03M -22.46M -22.9M -24.01M -21.45M -19.63M -20.64M -20.03M -22.36M -23.27M -21.75M -12.57M